MX2008001956A - Dihidroxiantraquinonas y su uso. - Google Patents

Dihidroxiantraquinonas y su uso.

Info

Publication number
MX2008001956A
MX2008001956A MX2008001956A MX2008001956A MX2008001956A MX 2008001956 A MX2008001956 A MX 2008001956A MX 2008001956 A MX2008001956 A MX 2008001956A MX 2008001956 A MX2008001956 A MX 2008001956A MX 2008001956 A MX2008001956 A MX 2008001956A
Authority
MX
Mexico
Prior art keywords
sub
dihydroxyanthraquinones
ocr
tetrazole
conr
Prior art date
Application number
MX2008001956A
Other languages
English (en)
Inventor
Andrew Douglas Baxter
Andrea Walmsley
Original Assignee
Sosei R & D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sosei R & D Ltd filed Critical Sosei R & D Ltd
Publication of MX2008001956A publication Critical patent/MX2008001956A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)

Abstract

Un compuesto de la formula (1), en donde X es H o -OCR1 y Y es H o -OCR2, con la condicion de que X y Y no sean ambos H; y R es CH2OR9, CONR11R12, CN, tetrazol o COOR17; o una sal del mismo, tiene utilidad terapeutica.
MX2008001956A 2005-08-10 2006-08-10 Dihidroxiantraquinonas y su uso. MX2008001956A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0516469.4A GB0516469D0 (en) 2005-08-10 2005-08-10 Novel compounds
PCT/GB2006/002999 WO2007017695A2 (en) 2005-08-10 2006-08-10 Dihydroxyanthraquinones and their use

Publications (1)

Publication Number Publication Date
MX2008001956A true MX2008001956A (es) 2008-04-07

Family

ID=34984419

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008001956A MX2008001956A (es) 2005-08-10 2006-08-10 Dihidroxiantraquinonas y su uso.

Country Status (13)

Country Link
US (1) US20080234258A1 (es)
EP (1) EP1912964A2 (es)
JP (1) JP2009504625A (es)
KR (1) KR20080043800A (es)
CN (1) CN101296916A (es)
AU (1) AU2006277794A1 (es)
BR (1) BRPI0614597A2 (es)
CA (1) CA2618069A1 (es)
GB (1) GB0516469D0 (es)
IL (1) IL189252A0 (es)
MX (1) MX2008001956A (es)
NO (1) NO20080710L (es)
WO (1) WO2007017695A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103083341B (zh) * 2011-10-31 2014-08-06 张雅珍 蒽环类抗生素在制备治疗年龄相关性黄斑变性的药物中的用途
KR101486147B1 (ko) * 2013-07-09 2015-01-23 주식회사 엘지생활건강 Tslp 분비 저해능 및 이에 의한 알러지성 질환의 개선능을 가지는 조성물
CN103641688B (zh) * 2013-12-25 2015-03-25 江苏省中国科学院植物研究所 脉络宁二氢蒽及其制备方法和用途
CN103709052B (zh) * 2014-01-12 2016-01-27 何黎琴 一种大黄酸胺基醇酯类化合物、其制备方法及医药用途
CN104557603A (zh) * 2014-12-08 2015-04-29 石河子大学 一种大黄酸类化合物及制备方法和应用
CN104529782A (zh) * 2014-12-16 2015-04-22 广西医科大学附属肿瘤医院 一种大黄酸多元醇的酯衍生物及制备抗肿瘤药物的用途
CN104892453A (zh) * 2015-01-27 2015-09-09 邵阳学院 大黄类抗菌、抗肿瘤化合物及其应用
CN104945269A (zh) * 2015-06-23 2015-09-30 常州善美药物研究开发中心有限公司 一种大黄酸羧酸酯类衍生物及其应用
US10420836B2 (en) * 2015-10-08 2019-09-24 Emory University Methods of immunizing a subject and compositions related thereto
CN109627169A (zh) * 2017-12-05 2019-04-16 何黎琴 No供体型大黄酸衍生物、其制备方法及医药用途
BR112021009136A2 (pt) 2018-11-14 2021-08-10 Zhuhai Qiwei Bio-Technology Ltd. método de triagem, método para a produção de um modelo de mamíferos, modelo animal e seu método de preparação, uso de uma quantidade eficaz de um antibiótico, de um composto e de um extrato

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2398780A (en) * 2003-02-26 2004-09-01 Arakis Ltd 1,8-dihydroxyanthraquinone-6-carboxamide derivatives as inhibitors of T-cell proliferation for treatment of autoimmune or inflammatory conditions
GB2398779A (en) * 2003-02-26 2004-09-01 Arakis Ltd 1,8-dihydroxyanthraquinone-6-carboxamide derivatives as modulators of IL-10 production for treatment of autoimmune or inflammatory conditions

Also Published As

Publication number Publication date
NO20080710L (no) 2008-04-25
IL189252A0 (en) 2008-08-07
CN101296916A (zh) 2008-10-29
EP1912964A2 (en) 2008-04-23
WO2007017695A3 (en) 2007-05-18
JP2009504625A (ja) 2009-02-05
WO2007017695A2 (en) 2007-02-15
US20080234258A1 (en) 2008-09-25
BRPI0614597A2 (pt) 2011-04-05
KR20080043800A (ko) 2008-05-19
AU2006277794A1 (en) 2007-02-15
CA2618069A1 (en) 2007-02-15
GB0516469D0 (en) 2005-09-14

Similar Documents

Publication Publication Date Title
MX2008001956A (es) Dihidroxiantraquinonas y su uso.
DE60336850D1 (en) Substituierte arylcyclopropylacetamide als glucokinaseaktivatoren
AU2003282983A8 (en) Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods
HK1069395A1 (en) Phthalazinone derivatives 2,3
ATE270817T1 (de) Fungizide
HK1079522A1 (en) Thienyl compounds
MXPA05011411A (es) 1,4-diazepinas sustituidas y usos de las mismas.
UA93351C2 (uk) Похідні фталазіну як інгібітори parp
NO20034291D0 (no) 2-aminopropanolderivater
TW200700393A (en) Novel cis-2,4,5-triaryl-imidazolines
MX2007005694A (es) Nuevos derivados de betulina, preparacion y uso de los mismos.
HK1080470A1 (en) Heterocyclic compounds
HK1079519A1 (en) Furyl compounds
EP1604665A4 (en) C-KIT KINASE HEMMER
ME01992B (me) Jedinjenje diarilhidantoina
MX2007005933A (es) Compuestos de acetamida como fungicidas.
WO2009016460A3 (en) Pyrazole compounds and their use as raf inhibitors
IL179607A0 (en) Indoles useful in the treatment of inflammation
IN2012DN02609A (es)
IN2012DN00758A (es)
GB0412769D0 (en) Organic compounds
SG170049A1 (en) Novel 11 beta - hydroxyandrosta-4-ene-3-ones
PH12009500610A1 (en) 4-imidazolin-2-one compounds
SE0004245D0 (sv) Novel compounds and their use
MY140666A (en) Biotinylated hexadecasaccharides, preparation and use thereof

Legal Events

Date Code Title Description
FA Abandonment or withdrawal